Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
B2HS2L, I've read the article, although not clear as where Novacyt has been involved. I accept that there's links between individuals at Proton DX and Novacyt, but what have we been doing and what might that mean for the bottom line. Also, will Katalyst continue to use Promate and the Q32, or has this been dropped in favour of the new Proton DX system. If Novacyt are involved, surely they'd become a distributor as well?
As usual, too many unanswered questions and we are simply stabbing in the dark.
It was four months ago Today that DA departed.
Perhaps JMC has been promised the CEO position, although first he has to prove that he can deliver and reverse the declining revenue, turn that corner and show that non-covid revenue is increasing. I guess that JMC was instrumental in the departure of DA, which might explain the silence.
Only a few weeks ago we learned that a new e-commerce platform was about to be launched, yesterday discovered that a new company video is being filmed. New vacancies, within both Sales and R&D.
Hoping that 'no news is good news.'
Okay, I take that back, can view his profile within Private Mode and can see that he liked a post from a Novacyt colleague earlier Today, however I still think an odd decision to block people and the vacancy as advertised is a very similar position to his own.
It was a couple of weeks ago, Antonio posted the vacancy the same week that Matthew’s profile vanished. Did Matthew leave suddenly and not work his notice period, I’m not sure, can only guess.
Consultants were paid a total of £1 million a day to work on the NHS Test and Trace system for more than a year of the pandemic, despite ministers being “very worried” about the spending.
WhatsApp messages between Matt Han****, then the health secretary, and his team of special advisers, show that he was shocked at learning the extent of Whitehall spending on external consultants to prop up the government’s ailing contact tracing system in January 2021.
He asked for the “exit strategy” and Emma Dean, his special adviser, said she had been “nagging” the department about it since November 2020.
Mr Han**** appears to have been made aware of the problem after David Williams, a senior civil servant, appeared before a parliamentary select committee on Jan 19, 2021.
The WhatsApp messages also raise fresh questions about the cost of the Test and Trace programme, which was accused by MPs of spending “unimaginable” sums and treating taxpayers “like an ATM machine” without making a “measurable difference” to case numbers in the UK.
The Lockdown Files show the nature of government during the Covid pandemic and how, despite public claims to always “follow the science”, key decisions were made on the fly for political reasons.
PM discovered second lockdown was based on ‘very wrong’ data
Mr Johnson was worried that he had “blinked too soon” in plunging Britain into a second national lockdown on the basis of data that scientists had warned him was “very wrong”.
He made the observation on Nov 1, 2020 – a day after he had announced a lockdown to come into force on Nov 4. Despite his fears, the lockdown went ahead and lasted for a month.
In one exchange, on Nov 1, 2020, Mr Johnson explained that he had been on a video conference call with scientists Dr Raghib Ali and Dr Carl Heneghan.
He told the WhatsApp group that Dr Heneghan said “the death modelling you have been shown is already very wrong”, as it was out of date having been drawn up three weeks previously.
Matt Handjob
I need to call in a favour tmrw
23:17
I currently have 22,000 spare slots tomorrow at my drive thrus. Hence I’ve extended eligibility today. Demand just isnt there. This is obvs good news about spread of virus. But hard for my target
23:18
So I really could do with a testing splash
23:18
Can we make this happen?
I WANT TO HIT MY TARGET!
Boris Johnson Prime Minister
Folks I am about to asked about masks in schools
Before we perform another u turn can I have a view on whether they are necessary
Matt Han****
Can you talk to CMO and see what we can do
14:21
Emma Dean
Emma Dean Department of Health Policy Special Adviser
Yes. What is your ask? Get rid or neutralise?
14:21
Matt Han****
Matt Han****
neutralise. Stop the defamation
The volume of people affected in turn makes it harder to treat them, she says, reducing capacity for the close monitoring of plasma leakage and fluid restoration required, which “leads to patients developing more complications and unfortunately higher mortality rates”.
Children have been worst affected by the current spread in Bolivia, and globally too, due to having weaker immune systems; a second dengue infection is five times more likely to kill a child than an adult.
Vaccines are seen by most as the only way of turning the tide on dengue, which the World Health Organization last year said could spark the next pandemic.
Yet “many high-income countries believe that dengue is not their problem,” according to Malavige, who points out that South Korea has been reporting 250 to 350 cases annually since 2016. Europe isn’t immune either, with cases cropping up across Italy and France last summer.“Funds need to be invested in developing treatment, biomarkers for prediction of those who will develop severe disease, and studies on understanding dengue disease pathogenesis better.”
Part of the difficulty is that dengue has four strains; developing a vaccine which can “protect simultaneously and equally against” all these different variants is challenging, says Regina Rabinovich, director of the Malaria Elimination Initiative at the Barcelona Institute for Global Health, describing dengue as a “terrifying disease”.
No dengue vaccine has yet to be globally approved: Qdenga received the regulatory nod in the UK last month, while Dengvaxia has been green-lit in the US. Another prevention option being trialled is Wolbachia, a bacteria used to infect mosquitoes, which makes it more difficult for the virus to replicate.
Without consensus on what works, though, the worsening situation in Bolivia is an indictment of what’s to come elsewhere, Malavige believes. “Dengue is everyone’s problem now.”